NCT03022968View on ClinicalTrials.gov

Tau Brain Imaging in Typical and Atypical Alzheimer's Disease (AD)

PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

January 10, 2017

Primary Completion Date

August 27, 2019

Study Completion Date

November 25, 2019

Conditions
Alzheimer DiseaseBenson's Disease
Interventions
DRUG

[18F]T807 PET

Imaging with \[18F\]T807 PET

Trial Locations (1)

37044

University Hospital of Tours, Tours

All Listed Sponsors
lead

University Hospital, Tours

OTHER

NCT03022968 - Tau Brain Imaging in Typical and Atypical Alzheimer's Disease (AD) | Biotech Hunter | Biotech Hunter